|
Age of diagnosis (Years [Mean ± SD])
| |
26.70 ± 12.75
|
|
Disease duration (Years [Mean ± SD])
| |
17.70 ± 14.95
|
|
Infectious onset, n (%)
| |
8 (80.0%)
|
|
Cognitive difficulties
|
Yes
|
10 (100%)
|
|
No
|
0 (0.0%)
|
|
Pain
|
Yes
|
10 (100%)
|
|
No
|
0 (0%)
|
|
Sleep disturbances
|
Yes
|
10 (100%)
|
|
No
|
0 (0%)
|
|
Sensory disturbances
|
Yes
|
9 (90.0%)
|
|
No
|
1 (10.0%)
|
|
Immune disturbances
|
Yes
|
9 (90.0%)
|
|
No
|
1 (10.0%)
|
|
Gastrointestinal disturbances
|
Yes
|
9 (90.0%)
|
|
No
|
1 (10.0%)
|
|
Cardiovascular disturbances
|
Yes
|
8 (80.0%)
|
|
No
|
2 (20.0%)
|
|
Respiratory disturbances
|
Yes
|
8 (90.0%)
|
|
No
|
2 (20.0%)
|
|
Thermostatic instability
|
Yes
|
10 (100%)
|
|
No
|
0 (0%)
|
|
Urinary disturbances
|
Yes
|
5 (50.0%)
|
|
No
|
5 (50.0%)
|
- ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SD standard deviation, n number
